DERMATITIS ATOPIC
Clinical trials for DERMATITIS ATOPIC explained in plain language.
Never miss a new study
Get alerted when new DERMATITIS ATOPIC trials appear
Sign up with your email to follow new studies for DERMATITIS ATOPIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Eczema Drug's Long-Term safety under the microscope in extended trial
Disease control TerminatedThis study aimed to check the long-term safety and effectiveness of an investigational drug called GSK1070806 for people with moderate-to-severe atopic dermatitis (eczema). It was an extension study for 79 participants who had already completed an earlier trial. The main goal was…
Matched conditions: DERMATITIS ATOPIC
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Drug trial aims to tame severe eczema itch and rash
Disease control TerminatedThis study tested an injectable drug called GSK1070806 to see if it could reduce the severity of eczema (atopic dermatitis) in adults. It compared different doses of the drug against a placebo injection over 16 weeks. The main goal was to see how much the drug could reduce the ex…
Matched conditions: DERMATITIS ATOPIC
Phase: PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
Doctors track new eczema Pill's Real-World impact
Knowledge-focused TerminatedThis study aimed to observe how well the prescription pill abrocitinib works and how safe it is for adults with moderate to severe eczema (atopic dermatitis) in real-world German clinics. It followed 112 patients who were already starting this medication as part of their normal c…
Matched conditions: DERMATITIS ATOPIC
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:25 UTC